News & HighlightsNews
Scientists can finally answer an old question about cellular aging
Replicative aging of human cells, the result of telomere shortening, is slower at physiological oxygen than at atmospheric oxygen, a difference now shown to be due to low oxygen impairing the ATM kinase response to withered telomeres.
Researchers develop a potential IVIG replacement for treating autoimmunity that’s significantly more potent
The discovery could greatly improve patient experience and address supply shortages.
Increasing levels of the protein PI31 demonstrates neuroprotective effects in mice
Boosting PI31 has been shown to head off Parkinson’s-like disorders and extend lifespan in fruit flies and mice, pointing to a possible new therapeutic target for treating rare neurodegenerative diseases, as well as more common disorders, such as Alzheimer's.
Mitochondrial antioxidant found to drive breast cancer metastasis
Researchers have learned that the antioxidant glutathione, when operating inside mitochondria, is a key factor enabling tumors to spread from the breast to the lung.
How new genes get switched on
After nearly a decade of cataloguing evolutionarily young genes, complementary studies are the first to demonstrate how they are regulated and expressed.
This brain circuit drives the urge to mate. Except when it doesn’t.
Scientists discovered an identical neural circuit that operates differently in male and female mice.
Mapping how nutrients move through the body to treat cancer
Kivanç Birsoy is uncovering the hidden metabolic pathways that cancer cells exploit. His work could also optimize strategies for using nutrition to improve human health.
Novel method dramatically improves cryo-EM’s imaging capabilities
Researchers have devised a way to visualize molecules that are very rare, very small, or hard to produce naturally—including some viruses.
Two Rockefeller researchers chosen for the Chan Zuckerberg Biohub New York Investigator Program 
Kivanç Birsoy and Ekaterina Vinogradova will head projects that aim to harness and bioengineer immune cells for the early detection, prevention, and treatment of disease.
Clinical trials show new antibody therapy offers long-lasting HIV control without daily medication
Results presented at Conference on Retroviruses and Opportunistic Infections show that two broadly neutralizing antibodies can keep HIV suppressed for months.
View
View